NHS accused of delaying access to 'highly tolerable' hepatitis C drugs over cost concerns
The NHS has been accused by leading health charities of attempting to “severely limit” the introduction of new drugs to treat hepatitis C because they are too expensive – despite the cost of them being cleared by officials. Independent
No comments:
Post a Comment